Publication:
Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

dc.contributor.authorRobles-Díaz, Mercedes
dc.contributor.authorLucena, M Isabel
dc.contributor.authorKaplowitz, Neil
dc.contributor.authorStephens, Camilla
dc.contributor.authorMedina-Cáliz, Inmaculada
dc.contributor.authorGonzález-Jiménez, Andrés
dc.contributor.authorUlzurrun, Eugenia
dc.contributor.authorGonzález, Ana F
dc.contributor.authorFernández, M Carmen
dc.contributor.authorRomero-Gómez, Manuel
dc.contributor.authorJiménez-Pérez, Miguel
dc.contributor.authorBruguera, Miguel
dc.contributor.authorPrieto, Martín
dc.contributor.authorBessone, Fernando
dc.contributor.authorHernández, Nelia
dc.contributor.authorArrese, Marco
dc.contributor.authorAndrade, Raúl J
dc.contributor.authoraffiliation[Robles-Díaz, M; Lucena, MI; Stephens, C; Medina-Cáliz, I; González-Jiménez, A; Ulzurrun, E; González, AF; Andrade, RJ] Unidad de Gestión Clínica de Enfermedades Digestivas, Servicio de Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Robles-Díaz, M; Lucena, MI; Stephens, C; Medina-Cáliz, I; Ulzurrun, E; Romero-Gómez, M; Bruguera, M; Prieto, M; Andrade, RJ] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain. [Kaplowitz, N] University of Southern California Research Center for Liver Diseases, Keck School of Medicine, Los Angeles, CA, United States. [Fernandez, MC] Servicio de Farmacia, Hospital de Torrecardenas, Almería, Spain. [ Romero-Gómez, M] Unidad de Gestión Clínica de Enfermedades Digestivas, Hospital Universitario de Valme, Sevilla, Spain. [Jiménez-Pérez, M] Unidad de Gestión Clínica de Enfermedades Digestivas, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario Carlos Haya, Málaga, Spain. [Bruguera, M] Instituto de Enfermedades Digestivas y Metabolismo, Hospital Clinic, Barcelona, Spain. [Prieto, M] Unidad de Gestión Clínica de Enfermedades Digestivas, Hospital la Fe, Valencia, Spain. [Bessone, F] Facultad de Ciencias Médicas, Servicio de Gastroenterología y Hepatología, Hospital Provincial del Centenario, Rosario, Argentina. [Hernández, N] Hospital de Clínicas Clínica de Gastroenterología, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay.es
dc.contributor.funderSupported by a research grant (Fondo de Investigación Sanitaria, PI12-00620), the Agencia Española del Medicamento, and the Innovative Medicines Initiative Safer and Faster Evidence-based Translation consortium (Framework Programme for Research and Technological Development (FP-7) grant agreement number 523 705, IMI-2008-T5). CIBERehd is funded by the Instituto de Salud Carlos III.
dc.date.accessioned2015-03-26T12:29:20Z
dc.date.available2015-03-26T12:29:20Z
dc.date.issued2014-07
dc.descriptionJournal Article;es
dc.description.abstractBACKGROUND & AIMS Hy's Law, which states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF). We aimed to optimize the definition of Hy's Law and to develop a model for predicting ALF in patients with DILI. METHODS We collected data from 771 patients with DILI (805 episodes) from the Spanish DILI registry, from April 1994 through August 2012. We analyzed data collected at DILI recognition and at the time of peak levels of alanine aminotransferase (ALT) and total bilirubin (TBL). RESULTS Of the 771 patients with DILI, 32 developed ALF. Hepatocellular injury, female sex, high levels of TBL, and a high ratio of aspartate aminotransferase (AST):ALT were independent risk factors for ALF. We compared 3 ways to use Hy's Law to predict which patients would develop ALF; all included TBL greater than 2-fold the upper limit of normal (×ULN) and either ALT level greater than 3 × ULN, a ratio (R) value (ALT × ULN/alkaline phosphatase × ULN) of 5 or greater, or a new ratio (nR) value (ALT or AST, whichever produced the highest ×ULN/ alkaline phosphatase × ULN value) of 5 or greater. At recognition of DILI, the R- and nR-based models identified patients who developed ALF with 67% and 63% specificity, respectively, whereas use of only ALT level identified them with 44% specificity. However, the level of ALT and the nR model each identified patients who developed ALF with 90% sensitivity, whereas the R criteria identified them with 83% sensitivity. An equal number of patients who did and did not develop ALF had alkaline phosphatase levels greater than 2 × ULN. An algorithm based on AST level greater than 17.3 × ULN, TBL greater than 6.6 × ULN, and AST:ALT greater than 1.5 identified patients who developed ALF with 82% specificity and 80% sensitivity. CONCLUSIONS When applied at DILI recognition, the nR criteria for Hy's Law provides the best balance of sensitivity and specificity whereas our new composite algorithm provides additional specificity in predicting the ultimate development of ALF.es
dc.description.versionYeses
dc.identifier.citationRobles-Diaz M, Lucena MI, Kaplowitz N, Stephens C, Medina-Cáliz I, González-Jimenez A, et al. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology. 2014 ; 147(1):109-118.e5es
dc.identifier.doi10.1053/j.gastro.2014.03.050
dc.identifier.essn1528-0012
dc.identifier.issn0016-5085
dc.identifier.pmid24704526
dc.identifier.urihttp://hdl.handle.net/10668/1859
dc.journal.titleGastroenterology
dc.language.isoen
dc.language.isoen
dc.organizationAGS Sur de Sevilla
dc.publisherWB Saunderses
dc.relation.publisherversionhttp://www.sciencedirect.com/science/article/pii/S0016508514004478es
dc.rights.accessRightsopen access
dc.subjectIdiosyncratic Hepatotoxicityes
dc.subjectPrognostic Risk Factores
dc.subjectPredictiones
dc.subjectProgressiones
dc.subjectComorbilidades
dc.subjectEnfermedad hepática inducida por drogases
dc.subjectIctericiaes
dc.subjectFallo hepático agudoes
dc.subjectValor predictivo de las pruebases
dc.subjectFactores de riesgoes
dc.subjectSensibilidad y especificidades
dc.subjectFactores sexualeses
dc.subjectAlanina transaminasaes
dc.subjectAlgoritmoses
dc.subjectBilirrubinaes
dc.subjectMarcadores biológicoses
dc.subjectNiñoses
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adultes
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged::Aged, 80 and overes
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Nitrogenous Group Transferases::Transaminases::Alanine Transaminasees
dc.subject.meshMedical Subject Headings::Information Science::Information Science::Computing Methodologies::Algorithmses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Esterases::Phosphoric Monoester Hydrolases::Alkaline Phosphatasees
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Transferases::Nitrogenous Group Transferases::Transaminases::Aspartate Aminotransferaseses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Pyrroles::Tetrapyrroles::Bile Pigments::Bilirubines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Biological Factors::Biological Markerses
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Childes
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studieses
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Comorbidityes
dc.subject.meshMedical Subject Headings::Diseases::Digestive System Diseases::Liver Diseases::Drug-Induced Liver Injuryes
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Hyperbilirubinemia::Jaundicees
dc.subject.meshMedical Subject Headings::Diseases::Digestive System Diseases::Liver Diseases::Hepatic Insufficiency::Liver Failure::Liver Failure, Acutees
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Agedes
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statisticales
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Epidemiologic Research Design::Sensitivity and Specificity::Predictive Value of Testses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studieses
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factorses
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Sensitivity and Specificityes
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Sex Factorses
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adult::Young Adultes
dc.subject.meshMedical Subject Headings::Named Groups::Persons::Age Groups::Adolescentes
dc.titleUse of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.es
dc.typeresearch article
dc.type.hasVersionAM
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RoblesDiaz_UseOfHysLaw.pdf
Size:
577.24 KB
Format:
Adobe Portable Document Format
Description:
Post-print (Versión del autor)